The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Gut hormone PYY3-36 physiologically inhibits food intake
Abstract
Food intake is regulated by the hypothalamus, including the melanocortin and neuropeptide Y (NPY) systems in the arcuate nucleus. The NPY Y2 receptor (Y2R), a putative inhibitory presynaptic receptor, is highly expressed on NPY neurons in the arcuate nucleus, which is accessible to peripheral hormones. Peptide YY(3-36) (PYY(3-36)), a Y2R agonist, is released from the gastrointestinal tract postprandially in proportion to the calorie content of a meal. Here we show that peripheral injection of PYY(3-36) in rats inhibits food intake and reduces weight gain. PYY(3-36) also inhibits food intake in mice but not in Y2r-null mice, which suggests that the anorectic effect requires the Y2R. Peripheral administration of PYY(3-36) increases c-Fos immunoreactivity in the arcuate nucleus and decreases hypothalamic Npy messenger RNA. Intra-arcuate injection of PYY(3-36) inhibits food intake. PYY(3-36) also inhibits electrical activity of NPY nerve terminals, thus activating adjacent pro-opiomelanocortin (POMC) neurons. In humans, infusion of normal postprandial concentrations of PYY(3-36) significantly decreases appetite and reduces food intake by 33% over 24 h. Thus, postprandial elevation of PYY(3-36) may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enteroendocrine cells sense nutrients in the intestinal lumen and produce peptides such as cholecystokinin (CCK), secretin, and the incretins; glucose‐dependent insulinotropic peptide (GIP); and glucagon‐like peptide 1 (GLP‐1) 19, 20.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [19]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Self-citationInteracting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horváth, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,564
Human distribution and release of a putative new gut hormone, peptide YY
Adrian, T. E., Ferri, G., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., & Bloom, S. R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90211-2 · Cited by 1,064
Self-citationGenetics of body-weight regulation
Barsh, G. S., Farooqi, I. S., & O’Rahilly, S. (2000) · Nature · doi:10.1038/35007519 · Cited by 783
c-Fos and Related Immediate Early Gene Products as Markers of Activity in Neuroendocrine Systems
Hoffman, G. E., Smith, M. S., & Verbalis, J. G. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1006 · Cited by 715
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
Edwards, C. M. B., Stanley, S. A., Davis, R. P., Brynes, A. E., Frost, G. S., Seal, L., Ghatei, M. A., & Bloom, S. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e155 · Cited by 468
Self-citationGrandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V. E., & Reeve, J. R. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90204-6 · Cited by 363
Cited by
Sorted by citations
Items 801–900 of 1,006
Brennan, I. M., Little, T. J., Feltrin, K. L., Smout, A. J. P. M., Wishart, J. M., Horowitz, M., & Feinle‐Bisset, C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90791.2008 · Cited by 48
Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Mittermayer, F., Caveney, E. J., OLIVEIRA, C. D. F., Gourgiotis, L., Puri, M., Tai, L.-J., & Turner, J. R. (2015) · Current Diabetes Reviews · doi:10.2174/1573399810666141224121927 · Cited by 48
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care
Danne, T., Biester, T., & Kordonouri, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0081 · Cited by 48
Enteroendocrine Regulation of Nutrient Absorption
McCauley, H. A. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz191 · Cited by 48
Dairy-derived peptides for satiety
Kondrashina, A. V., Brodkorb, A., & Giblin, L. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103801 · Cited by 48
Peptides in the regulation of glucagon secretion
Andersen, D. B., & Holst, J. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170683 · Cited by 50
Effect of peripheral obestatin on food intake and gastric emptying in ghrelin‐knockout mice
Depoortere, I., Thijs, T., Moechars, D., Smet, B., Donck, L. V., & Peeters, T. L. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707683 · Cited by 48
Nguyen, N. Q., Fraser, R. J., Bryant, L. K., Chapman, M. J., Wishart, J. M., Holloway, R. H., Butler, R. N., & Horowitz, M. (2007) · Critical Care · doi:10.1186/cc6205 · Cited by 48
Neary, N. M., Small, C. J., & Bloom, S. R. (2003) · Gut · doi:10.1136/gut.52.7.918 · Cited by 48
Self-citationMarciani, L., Cox, E. F., Pritchard, S. E., Major, G., Hoad, C. L., Mellows, M., Hussein, M. O., Costigan, C. M., Fox, M. R., Gowland, P. A., et al. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.194 · Cited by 48
Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice
Shechter, Y., Tsubery, H., Mironchik, M., Rubinstein, M., & Fridkin, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.044 · Cited by 48
Katz, L., Gambale, J. J., Rothenberg, P., Vanapalli, S. R., Vaccaro, N. M., Xi, L., Polidori, D., Vets, E., Sarich, T. C., & Stein, P. P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.169 · Cited by 47
Anorexia of Aging and Gut Hormones
Atalayer, D. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400264 · Cited by 47
Food Components with Anti-Obesity Effect
Kim, K., & Park, Y. (2011) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022510-133656 · Cited by 47
Zhang, Y., Zhang, Y., Huang, L., Zhou, Z., Wang, J., Liu, H., & Wu, H. (2016) · Electrochimica Acta · doi:10.1016/j.electacta.2016.02.092 · Cited by 47
Makaronidis, J., & Batterham, R. L. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.006 · Cited by 48
Self-citationDorton, H. M., LUO, S. H., Monterosso, J. R., & Page, K. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00297 · Cited by 47
Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)
El‐Salhy, M., Hatlebakk, J. G., & Hausken, T. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101973 · Cited by 47
Yau, Y. F., El-Nezami, H. S., Galano, J., Kundi, Z. M., Durand, T., & Lee, J. C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000566 · Cited by 47
Old Paradoxes and New Opportunities for Appetite Control in Obesity
Montégut, L., López-Otín, C., Magnan, C., & Kroemer, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.005 · Cited by 48
Huang, L., Tan, H. Y., Fogarty, M. J., Andrews, Z. B., Veldhuis, J. D., Herzog, H., Steyn, F. J., & Chen, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4622-13.2014 · Cited by 47
Self-citationNeuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat
Zengin, A., Zhang, L., Herzog, H., Baldock, P. A. J., & Sainsbury, A. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.02.004 · Cited by 47
Self-citationSainsbury, A., Bergen, H., Boey, D., Bamming, D., Cooney, G. J., Lin, S., Couzens, M., Stroth, N., Lee, N. J., Lindner, D., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0472 · Cited by 47
Self-citationSatiety Associated with Calorie Restriction and Time-Restricted Feeding: Peripheral Hormones
Tacad, D. K., Tovar, A. P., Richardson, C. E., Horn, W. F., Krishnan, G. P., Keim, N. L., & Krishnan, S. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac014 · Cited by 46
Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake
Serrano, A., Pavón, F. J., Tovar, S. A., Casanueva, F. F., Señarís, R. M., Diéguez, C., & de Fonseca, F. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.007 · Cited by 46
Riediger, T. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000778 · Cited by 46
Khosravi, Y., Seow, S. W., Amoyo, A. A., Chiow, K. H., Tan, T. L., Wong, W. Y., Poh, Q. H., Sentosa, I. M. D., Bunte, R. M., Pettersson, S., et al. (2015) · Scientific Reports · doi:10.1038/srep08731 · Cited by 46
Regulation of appetite to treat obesity
Kim, G. W., Lin, J. E., Valentino, M. A., Colón‐González, F., & Waldman, S. A. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.3 · Cited by 46
The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
Guida, C., Stephen, S., Guitton, R., & Ramracheya, R. D. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.04.005 · Cited by 46
The role of epigenetics in hypothalamic energy balance control: implications for obesity
Obri, A., & Claret, M. (2019) · Cell Stress · doi:10.15698/cst2019.07.191 · Cited by 46
Gut peptide regulation of food intake – evidence for the modulation of hedonic feeding
Woodward, O. R. M., Gribble, F. M., Reimann, F., & Lewis, J. E. (2021) · The Journal of Physiology · doi:10.1113/jp280581 · Cited by 46
Yamada, T., Oka, Y., & Katagiri, H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.006 · Cited by 46
The central melanocortin system and the regulation of energy balance
Lee, M. (2007) · Frontiers in Bioscience · doi:10.2741/2366 · Cited by 45
Beale, K. E., Gardiner, J., Bewick, G. A., Hostomska, K., Patel, N. G., Hussain, S., Jayasena, C. N., Ebling, F., Jethwa, P. H., Prosser, H. M., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02191.x · Cited by 45
Self-citationGhrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis
Dong, C. X., & Brubaker, P. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.185 · Cited by 45
Anorexigenic Effects of GLP-1 and Its Analogues
Gallwitz, B. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_8 · Cited by 45
Counterregulation of insulin by leptin as key component of autonomic regulation of body weight
Borer, K. T. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.606 · Cited by 45
Lessons Learned from Gastric Bypass Operations in Rats
Seyfried, F., le Roux, C. W., & Bueter, M. (2011) · Obesity Facts · doi:10.1159/000327301 · Cited by 45
Wu, W., Zhou, H.-R., He, K., Pan, X., Sugita‐Konishi, Y., Watanabe, M., Zhang, H., & Pestka, J. J. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft335 · Cited by 45
Lensing, C. J., Freeman, K. T., Schnell, S. M., Adank, D. N., Speth, R. C., & Haskell‐Luevano, C. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01894 · Cited by 45
Wu, W., Zhou, H.-R., Bursian, S. J., Pan, X., Link, J. E., Berthiller, F., Adam, G., Krantis, A., Durst, T., & Pestka, J. J. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu166 · Cited by 45
Melanocortin neurons: Multiple routes to regulation of metabolism
Shen, W.-J., Yao, T. S., Kong, X., Williams, K. W., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.007 · Cited by 45
Grembi, J. A., Nguyen, L. H., Haggerty, T. D., Gardner, C. D., Holmes, S., & Parsonnet, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58000-y · Cited by 45
The thyroid hormone derivative 3‐iodothyronamine increases food intake in rodents
Dhillo, W. S., Bewick, G. A., White, N. E., Gardiner, J., Thompson, E. L., Bataveljic, A., Murphy, K. G., Roy, D., Patel, N. A., Scutt, J. N., et al. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00935.x · Cited by 45
Self-citationHill, B. R., Souza, M. J. D., & Williams, N. I. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00171.2011 · Cited by 45
Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats
Unniappan, S., & Kieffer, T. J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00234.2007 · Cited by 45
Neuroendocrine control of food intake
Park, A. J., & Bloom, S. R. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000153358.05901.3f · Cited by 45
Self-citationDagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
Neuroendocrine Control of Food Intake
Butler, A. A., Trevaskis, J. L., & Morrison, C. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-32164-6_1 · Cited by 44
Gao, J., Zhang, S., Deng, P., Wu, Z., Lemaître, B., Zhai, Z., & Guo, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-47465-4 · Cited by 46
Possible Mechanisms of Circulating PYY-Induced Satiation in Male Rats
Weber‐Stadlbauer, U., Arnold, M., Weber, E., & Langhans, W. (2012) · Endocrinology · doi:10.1210/en.2012-1956 · Cited by 44
Bonaventure, P., Nepomuceno, D. H., Mazur, C., Lord, B., Rudolph, D. A., Jablonowski, J. A., Carruthers, N. I., & Lovenberg, T. W. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060459 · Cited by 44
Michalakis, K. G., & le Roux, C. W. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0698-9 · Cited by 44
Zhang, Y., Rahematpura, S., Ragnini, K., Moreno, A., Stecyk, K. S., Kahng, M. W., Milliken, B. T., Hayes, M. R., Doyle, R. P., & Schmidt, H. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108599 · Cited by 44
Expression of the glucocorticoid-induced receptor mRNA in rat brain
Sah, R., Pritchard, L. M., Richtand, N. M., Ahlbrand, R., Eaton, K., Sallee, F. R., & Herman, J. P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.066 · Cited by 44
Bewick, G. A., Dhillo, W. S., Darch, S. J., Murphy, K. G., Gardiner, J., Jethwa, P. H., Kong, W. M., Ghatei, M. A., & Bloom, S. R. (2005) · Endocrinology · doi:10.1210/en.2004-1659 · Cited by 44
Self-citationle Roux, C. W., Ghatei, M. A., Gibbs, J. S. R., & Bloom, S. R. (2005) · Heart · doi:10.1136/hrt.2003.026880 · Cited by 44
Self-citationMetformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes
English, P., Ashcroft, A., Patterson, M., Dovey, T. M., Halford, J. C. G., Harrison, J., Eccleston, D., Bloom, S. R., Ghatei, M. A., & Wilding, J. P. H. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.681 · Cited by 44
Self-citationEmerging aspects of pharmacotherapy for obesity and metabolic syndrome
Nisoli, E., & Carruba, M. O. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.02.004 · Cited by 44
Lower mean weight after 14 days intravenous administration peptide YY3–36 (PYY3–36) in rabbits
Sileno, A. P., Brandt, G., Spann, B. M., & Quay, S. C. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803067 · Cited by 44
Peripheral neural targets in obesity
Page, A. J., Symonds, E. L., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01951.x · Cited by 43
Pazos, Y., Alvarez, C. J. P., Camiña, J. P., & Casanueva, F. F. (2007) · Growth Factors · doi:10.1080/08977190801889313 · Cited by 43
Oat beta-glucan as a dietary supplement for dogs
Ferreira, L. G., Endrighi, M., Lisenko, K. G., de Oliveira, M. R. D., Damasceno, M. R., Claudino, J. A., Gutierres, P. G., Peconick, A. P., Saad, F. M. D. O. B., & Zangerônimo, M. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201133 · Cited by 43
Physiology of energy homeostasis: Models, actors, challenges and the glucoadipostatic loop
Chapelot, D., & Charlot, K. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.012 · Cited by 43
Gustatory and reward brain circuits in the control of food intake
Oliveira-Maia, A. J., Roberts, C. D., Simon, S. A., & Nicolelis, M. A. L. (2010) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-7091-0179-7_3 · Cited by 43
Ziemek, R., Brennauer, A., Schneider, E. H., Cabrele, C., Beck‐Sickinger, A. G., Bernhardt, G., & Buschauer, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.075 · Cited by 43
Xu, J., McNearney, T. A., & Chen, J. D. Z. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9049-7 · Cited by 43
Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs
Lecklin, A., Lundell, I., Salmela, S., Männistö, P. T., Beck‐Sickinger, A. G., & Larhammar, D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705389 · Cited by 43
Dumont, Y., Moyse, E., Fournier, A., & Quirion, R. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9007-9 · Cited by 43
Axon‐Like Basal Processes in Enteroendocrine Cells: Characteristics and Potential Targets
Bohórquez, D. V., & Liddle, R. A. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00299.x · Cited by 43
Gastrointestinal Satiety Signals IV. Apolipoprotein A-IV
Tso, P., Sun, W. Y., & Liu, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00511.2003 · Cited by 43
Rosenkilde, M., Reichkendler, M. H., Auerbach, P., Toräng, S., Gram, A. S., Ploug, T., Holst, J. J., Sjödin, A. M., & Stallknecht, B. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00680.2013 · Cited by 43
Bays, H. E., & Dujovne, C. A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.9.1189 · Cited by 43
Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity
Andersson-Hall, U. K., Treebak, J. T., Nielsen, J. N., Smith, K. L., Abbott, C. R., Small, C. J., Carling, D., & Richter, E. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.027 · Cited by 43
Self-citationSjödin, P., Holmberg, S. K. S., Åkerberg, H., Berglund, M. M., Mohell, N., & Larhammar, D. (2005) · Biochemical Journal · doi:10.1042/bj20050708 · Cited by 43
Why Do Patients Lose Weight after Roux-en-Y Gastric Bypass?
le Roux, C. W., & Bloom, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2211 · Cited by 43
Self-citationEstablished and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes
Lafferty, R. A., Flatt, P. R., & Irwin, N. (2021) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000612 · Cited by 42
Acute sleep restriction alters neuroendocrine hormones and appetite in healthy male adults
MAGEE, C. A., HUANG, X.-F., IVERSON, D. C., & CAPUTI, P. (2009) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2009.00396.x · Cited by 42
The role of gut hormones in appetite regulation (review)
Maric, G. D., Gazibara, T. M., Zaletel, I. V., Labudović‐Borović, M., Tomanović, N., Ćirić, M., & Puškaš, N. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.4.1 · Cited by 42
Seimon, R. V., Feltrin, K. L., Meyer, J. H., Brennan, I. M., Wishart, J. M., Horowitz, M., & Feinle‐Bisset, C. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90934.2008 · Cited by 42
Ghrelin but Not Peptide YY Is Related to Change in Body Weight and Energy Availability
Scheid, J. L., Souza, M. J. D., Leidy, H. J., & Williams, N. I. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821e52ab · Cited by 42
Hata, T., Mera, Y., Ishii, Y., Tadaki, H., Tomimoto, D., Kuroki, Y., Kawai, T., Ohta, T., & Kakutani, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176560 · Cited by 42
Neuropeptides in Obesity and Metabolic Disease
van der Klaauw, A. A. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.281568 · Cited by 42
Blood-to-brain communication in the hypothalamus for energy intake regulation
Takemura, S., & Wanaka, A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.007 · Cited by 42
Appetite, the enteroendocrine system, gastrointestinal disease and obesity
Crooks, B. J., Stamataki, N. S., & McLaughlin, J. T. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120006965 · Cited by 42
Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Escobedo, G., López‐Ortiz, E., & Torres-Castro, I. (2014) · PubMed · Cited by 42
Sawicki, C. M., Lichtenstein, A. H., Rogers, G. T., Jacques, P. F., Ma, J., Saltzman, E. J., & McKeown, N. M. (2021) · Nutrients · doi:10.3390/nu13030997 · Cited by 43
Endocrine Modulation of Olfactory Responsiveness: Effects of the Orexigenic Hormone Ghrelin
Loch, D., Breer, H., & Strotmann, J. M. (2015) · Chemical Senses · doi:10.1093/chemse/bjv028 · Cited by 42
Psychological Disturbances and Quality of Life in Obese and Infertile Women and Men
Kocełak, P., Chudek, J. T., Naworska, B., Bąk‐Sosnowska, M., Kotlarz, B., Mazurek, M., Madej, P., Skrzypulec‐Plinta, V., Skałba, P., & Olszanecka‐Glinianowicz, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/236217 · Cited by 42
Dose-dependent effects of peptide YY(3-36) on conditioned taste aversion in rats
Chelikani, P. K., Haver, A. C., & Reidelberger, R. D. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.001 · Cited by 42
Weber‐Stadlbauer, U., Langhans, W., & Meyer, U. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.146 · Cited by 42
Yang, N., Liu, X., Ding, E. L., Xu, M., Wu, S., Liu, L., Sun, X., & Hu, F. B. (2009) · Journal of Nutrition · doi:10.3945/jn.109.104406 · Cited by 42
Comprehensive review on herbal medicine for energy intake suppression
Yuliana, N. D., Jahangir, M., Korthout, H. A. A. J., Choi, Y. H., Kim, H. K., & Verpoorte, R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00790.x · Cited by 42
Macronutrients and obesity: Revisiting the calories in, calories out framework
Riera‐Crichton, D., & Tefft, N. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2014.04.002 · Cited by 42
The Anorexigenic Fatty Acid Synthase Inhibitor, C75, Is a Nonspecific Neuronal Activator
Takahashi, K. A., Smart, J. L., Liu, H., & Cone, R. D. (2003) · Endocrinology · doi:10.1210/en.2003-0337 · Cited by 42
Self-citationHypothalamic inflammation and food intake regulation during chronic illness
Dwarkasing, J. T., Marks, D. L., Witkamp, R. F., & van Norren, K. (2015) · Peptides · doi:10.1016/j.peptides.2015.06.011 · Cited by 41
Xanthakos, S. A. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.04.005 · Cited by 41
Álvarez-Castro, P., Sangiao‐Alvarellos, S., Brandón-Sandá, I., & Cordido, F. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.008 · Cited by 41
Functional neuroimaging in obesity and the potential for development of novel treatments
Schlögl, H., Horstmann, A., Villringer, A., & Stümvoll, M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00475-1 · Cited by 41
New Targets for Drug Treatment of Obesity
Valsamakis, G., Konstantakou, P., & Mastorakos, G. P. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104735 · Cited by 41
Metadata
- Authors
- Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., Cone, R. D., & Bloom, S. R.
- Affiliations
- Imperial College London (GB)
- Oregon National Primate Research Center (US)
- Garvan Institute of Medical Research (AU)
- Oregon Health & Science University (US)
- Corresponding author
- Bloom, Stephen R.
- ORCID
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6898
- Pages
- 650-654
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2091685843
- Cited by
- 2,351
- References
- 25
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 53 · 2022: 73 · 2021: 106 · 2020: 73 · 2019: 92 · 2018: 97 · 2017: 70 · 2016: 73 · 2015: 98 · 2014: 97 · 2013: 121 · 2012: 121
- FWCI
- 38.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- PYY3-36, food intake regulation, arcuate nucleus, hypothalamus, proopiomelanocortin neurons, postprandial satiety, appetite, weight gain, c-fos, NPY neurons
- MeSH terms
- Action Potentials, Animals, Appetite, Arcuate Nucleus of Hypothalamus, Body Weight, Energy Intake, Electrophysiology, Feeding Behavior, Humans, Injections, Intraperitoneal, Injections, Intraventricular, Male, Mice, Inbred C57BL, Neurons, Peptide Fragments, Pro-Opiomelanocortin, Signal Transduction, Proto-Oncogene Proteins c-fos, Rats, Wistar, Gene Deletion, Receptors, Neuropeptide Y, Mice, Knockout, Peptide YY, Leptin, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review